详细信息
文献类型:期刊文献
中文题名:复方玄驹胶囊治疗前列腺炎疗效观察
英文题名:Effect of compound xuanju capsule on treating prostatitis
作者:王欣[1];苏晶石[1];刘铸[1];杨可为[1]
机构:[1]绍兴文理学院附属医院泌尿外科
年份:2011
卷号:21
期号:10
起止页码:2045
中文期刊名:中华医院感染学杂志
外文期刊名:Chinese Journal of Nosocomiology
收录:CSTPCD、、北大核心2008、CSCD_E2011_2012、北大核心、CSCD
语种:中文
中文关键词:复方玄驹胶囊;前列腺炎;疗效
外文关键词:Compound xuanju Capsule; Prostatitis; Curative effect
中文摘要:目的探讨复方玄驹胶囊治疗前列腺炎的临床疗效。方法 220例Ⅱ型和Ⅲ型慢性前列腺炎患者,口服复方玄驹胶囊两个疗程,观察治疗前后国际慢性前列腺炎症状评分(NIH-CPSI)、国际勃起功能指数(IIEF-5)、抑郁自评量表(SDS)评分、焦虑自评量表(SAS)评分变化,并评价疗效。结果 NIH-CPSI评分(疼痛与不适评分、尿路症状评分、生活质量评分)比治疗前明显降低(P<0.01);IIEF-5评分比治疗前明显升高(P<0.01);治疗前SDS和SAS评分均明显高于国内常模(P<0.01),治疗后均显著下降(P<0.01);总有效率为88.2%,其中Ⅱ型92.3%,Ⅲ型85.9%(P>0.05);复发率为13.5%,其中Ⅱ型7.8%,Ⅲ型13.8%。结论复方玄驹胶囊对Ⅱ型和Ⅲ型前列腺炎均有确切疗效,且能显著改善勃起功能障碍和神经衰弱症状,复发率低,安全性高,值得临床推广应用。
外文摘要:OBJECTIVE To observe the curative effect of Compound Xuanju Capsule on treatment of prostatitis.METHODS A total of 220 prostatitis patients were treated with Compound Xuanju Capsule at 3 capsules per times for 8 weeks.National Institutes of Health-Chronic Prostatitis symptom Score(NIH-CPSI),International Index of Erectile Function-5(IIEF-5),Self-rating Depression Scale(SDS) and Self-rating Anxiety Scale(SAS) score were observed.The efficacy was evaluated by serf-control comparison.RESULTS NIH-CPSI score(Pain and discomfort score,urinary symptom scores,quality of life score) was significantly lower than that before treatment(P0.01);IIEF-5 score was significantly higher than before treatment(P0.01);SDS and SAS scores of before treatment were significantly higher than the national norm(P0.01),decreased significantly after treatment(P0.01);The total effective rate was 88.2%(194/220),Type Ⅱ 92.3%(72/78),Type Ⅲ85.9%(122/142)(P0.05);Recurrence rate was 13.5%(15/111),Type Ⅱ 7.8%(4/51),Type Ⅲ13.8%(11/80)(P0.05).CONCLUSION Compound Xuanju Capsule on treating Type Ⅱ and type Ⅲ prostatitis has the exact curative effect,can significantly improve the erectile dysfunction and symptoms of neurasthenia,recurrence rate,high security,and it is worthy of being promoted in clinics.
参考文献:
正在载入数据...